196 related articles for article (PubMed ID: 11598385)
1. Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
Razzaque MS; Hossain MA; Ahsan N; Taguchi T
Nephron; 2001 Nov; 89(3):251-4. PubMed ID: 11598385
[TBL] [Abstract][Full Text] [Related]
2. Lipid formulations of amphotericin B. Less toxicity but at what economic cost?
Tollemar J; Ringdén O
Drug Saf; 1995 Oct; 13(4):207-18. PubMed ID: 8573294
[No Abstract] [Full Text] [Related]
3. Lipid-based formulations of amphotericin B.
Plotnick AN
J Am Vet Med Assoc; 2000 Mar; 216(6):838-41. PubMed ID: 22570893
[No Abstract] [Full Text] [Related]
4. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.
Craddock C; Anson J; Chu P; Dodgson A; Duncan N; Gomez C; Mehta J; Sadullah S; Subudhi C; Yin JL
Expert Opin Drug Saf; 2010 Jan; 9(1):139-47. PubMed ID: 19947901
[TBL] [Abstract][Full Text] [Related]
5. ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous.
Koczmara C; Richardson H; Hyland S; Lee CS; Hillebrand N
Dynamics; 2011; 22(1):24-6. PubMed ID: 21469498
[TBL] [Abstract][Full Text] [Related]
6. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
Frothingham R
Clin Infect Dis; 2002 Oct; 35(7):896-7; author reply 897-8. PubMed ID: 12228830
[No Abstract] [Full Text] [Related]
7. Liposomal and lipid-based formulations of amphotericin B.
de Marie S
Leukemia; 1996 Jun; 10 Suppl 2():s93-6. PubMed ID: 8649062
[TBL] [Abstract][Full Text] [Related]
8. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
Bes DF; Rosanova MT; Sberna N; Arrizurieta E
Pediatr Infect Dis J; 2014 Aug; 33(8):e198-206. PubMed ID: 24618932
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC;
Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223
[TBL] [Abstract][Full Text] [Related]
10. [Lipid formulations of amphotericin].
Botero MC; Puentes-Herrera M; Cortés JA
Rev Chilena Infectol; 2014 Oct; 31(5):518-27. PubMed ID: 25491449
[TBL] [Abstract][Full Text] [Related]
11. Lipid formulations of amphotericins: are you a lumper or a splitter?
Wingard JR
Clin Infect Dis; 2002 Oct; 35(7):891-5. PubMed ID: 12228829
[No Abstract] [Full Text] [Related]
12. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.
Mistro S; Maciel Ide M; de Menezes RG; Maia ZP; Schooley RT; Badaró R
Clin Infect Dis; 2012 Jun; 54(12):1774-7. PubMed ID: 22491505
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B formulations and drug targeting.
Torrado JJ; Espada R; Ballesteros MP; Torrado-Santiago S
J Pharm Sci; 2008 Jul; 97(7):2405-25. PubMed ID: 17893903
[TBL] [Abstract][Full Text] [Related]
14. Lipid formulations of amphotericin B.
Jones E; Goldman M
Cleve Clin J Med; 1998 Sep; 65(8):423-7. PubMed ID: 9769563
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.
Messori A; Fadda V; Maratea D; Trippoli S; Marinai C
Clin Infect Dis; 2013 Dec; 57(12):1783-4. PubMed ID: 24140972
[No Abstract] [Full Text] [Related]
16. Nephrotoxicity in the setting of invasive fungal diseases.
Ullmann AJ
Mycoses; 2008; 51 Suppl 1():25-30. PubMed ID: 18471158
[TBL] [Abstract][Full Text] [Related]
17. Development of liposomal polyene antibiotics: an historical perspective.
Ng AW; Wasan KM; Lopez-Berestein G
J Pharm Pharm Sci; 2003; 6(1):67-83. PubMed ID: 12753730
[TBL] [Abstract][Full Text] [Related]
18. Lipid formulations of amphotericin B: clinical efficacy and toxicities.
Wong-Beringer A; Jacobs RA; Guglielmo BJ
Clin Infect Dis; 1998 Sep; 27(3):603-18. PubMed ID: 9770163
[TBL] [Abstract][Full Text] [Related]
19. A comparative review of conventional and lipid formulations of amphotericin B.
Robinson RF; Nahata MC
J Clin Pharm Ther; 1999 Aug; 24(4):249-57. PubMed ID: 10475983
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based antifungal agents: a concise overview.
Arikan S
Cell Mol Biol Lett; 2002; 7(3):919-22. PubMed ID: 12378276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
